Adaptimmune Therapeutics EPS Diluted (TTM) Insights

Adaptimmune Therapeutics PLC (ADAP)

1.08 -0.04 (-3.57%) USD | NASDAQ | Apr 24, 16:00

1.08 0.00 (0.00%) After-Hours: 20:00

EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	-0.4738
September 30, 2023	-0.4738
June 30, 2023	-0.5338
March 31, 2023	-0.7138
December 31, 2022	-1.02
September 30, 2022	-1.08
June 30, 2022	-1.14
March 31, 2022	-1.08
December 31, 2021	-1.02
September 30, 2021	-1.02
June 30, 2021	-0.96
March 31, 2021	-0.96
December 31, 2020	-0.96
September 30, 2020	-1.02
June 30, 2020	-1.14
March 31, 2020	-1.32

Date	Value
December 31, 2019	-1.32
September 30, 2019	-1.38
June 30, 2019	-0.96
March 31, 2019	-1.02
December 31, 2018	-1.02
September 30, 2018	-0.96
June 30, 2018	-1.029
March 31, 2018	-0.7894
December 31, 2017	-0.8494
September 30, 2017	-0.7894
June 30, 2017	-1.02
March 31, 2017	-1.08
December 31, 2016	-1.02
September 30, 2016	-0.7982
June 30, 2016	-0.5619
March 31, 2016	-0.2696

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (TTM) Range, Past 5 Years

-1.38

Minimum

Sep 2019

-0.4738

Maximum

Sep 2023

-0.9776

Average

-1.02

Median

Sep 2020

EPS Diluted (TTM) Benchmarks